Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Income Before Tax

Profit after all operating and non-operating items but before income tax.

No reported Income Before Tax figures are available to summarize.

Income Before Tax history

Currency unavailable · from the income statement

No Income Before Tax data reported for this period type.

Income Before Tax vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Income Before Tax for AVLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GYREGyre Therapeutics, Inc.LTM Mar 2026$564K USD-96.3%+15.3%0.5%
MNKDMannKind CorporationLTM Mar 2026-$28.58M USD-186.0%—7.9%
VCREVicore Pharma Holding ABLTM Jun 2026-SEK 272.4M SEK+30.8%—20481.7%
INSMInsmed IncorporatedLTM Jun 2026-$869.11M USD+15.6%—76.4%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-40.4%+15.3%42.2%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.